Micro Text Module #4 with downloadable slides

Optimizing Outcomes and QoL Through Effective Management of ADC-Associated Toxicities

Share

Program Content

Activities

  • TROP2 Targeted Therapy: Module
    TROP-2–Targeted Therapy: Redefining the Therapeutic Landscape in HER2-Negative Breast Cancer
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 22, 2024

    Expires: February 21, 2025

  • TROP2 Targeted Therapy: Slides
    TROP-2–Targeted Therapy: Redefining the Therapeutic Landscape in HER2-Negative Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: February 22, 2024

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.